146 related articles for article (PubMed ID: 2048910)
1. [The efficacy of cholestyramine as a hypocholesterolemic agent and its tolerance in a Mexican population].
Lerman Garber I; Cardoso Saldaña G; Zamora González J; Ahumada Ayala M; García Rubí E; Posadas Romero C
Arch Inst Cardiol Mex; 1991; 61(1):47-51. PubMed ID: 2048910
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia.
Denke MA; Grundy SM
Arch Intern Med; 1995 Feb; 155(4):393-9. PubMed ID: 7848022
[TBL] [Abstract][Full Text] [Related]
3. [Effects of low-dose cholestyramine in long-term therapy of hypercholesterolemia].
Cattin L; Da Col PG; Fonda M; Mazzone C; Pertot P
G Clin Med; 1990 Feb; 71(2):99-104. PubMed ID: 2347462
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
[TBL] [Abstract][Full Text] [Related]
5. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR
Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804
[TBL] [Abstract][Full Text] [Related]
6. [Cholestyramine in the treatment of hypercholesterolemia. Our experience in 11 cases].
Maíz A; Arteaga A; Villanueva CL; Velasco N; Acosta AM
Rev Med Chil; 1990 Sep; 118(9):1009-13. PubMed ID: 2152729
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial.
Illingworth DR; Stein EA; Mitchel YB; Dujovne CA; Frost PH; Knopp RH; Tun P; Zupkis RV; Greguski RA
Arch Intern Med; 1994 Jul; 154(14):1586-95. PubMed ID: 8031206
[TBL] [Abstract][Full Text] [Related]
9. Therapy of familial hypercholesterolemia in childhood: diet and cholestyramine resin for 24 to 36 months.
Glueck CJ; Tsang RC; Fallat RW; Mellies M
Pediatrics; 1977 Mar; 59(3):433-41. PubMed ID: 840563
[TBL] [Abstract][Full Text] [Related]
10. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J
Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396
[TBL] [Abstract][Full Text] [Related]
11. Psyllium for the reduction of cholestyramine-associated gastrointestinal symptoms in the treatment of primary hypercholesterolemia.
Maciejko JJ; Brazg R; Shah A; Patil S; Rubenfire M
Arch Fam Med; 1994 Nov; 3(11):955-60. PubMed ID: 7804477
[TBL] [Abstract][Full Text] [Related]
12. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
Sommariva D; Bonfiglioli D; Tirrito M; Pogliaghi I; Branchi A; Cabrini E
Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
[TBL] [Abstract][Full Text] [Related]
13. A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group III.
JAMA; 1988 Jul; 260(3):359-66. PubMed ID: 2898027
[TBL] [Abstract][Full Text] [Related]
14. [Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia].
Carlson LA; Olsson AG; Orö L; Rössner S
Lakartidningen; 1974 Sep; 71(36):3289-91. PubMed ID: 4605566
[No Abstract] [Full Text] [Related]
15. Effect of lovastatin on serum lipids in patients with nonfamilial primary hypercholesterolemia.
Itskovitz HD; Flamenbaum W; De Gaetano C; Pritchard KA; Stemerman MB
Clin Ther; 1989; 11(6):862-72. PubMed ID: 2611825
[TBL] [Abstract][Full Text] [Related]
16. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
Saku K; Sasaki J; Arakawa K
Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
[TBL] [Abstract][Full Text] [Related]
17. Contrasting effects of lovastatin and cholestyramine on low-density lipoprotein cholesterol and 24-hour urinary mevalonate excretion in patients with heterozygous familial hypercholesterolemia.
Pappu AS; Illingworth DR
J Lab Clin Med; 1989 Nov; 114(5):554-62. PubMed ID: 2809398
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of bezafibrate and of a bezafibrate and cholestyramine combination on lipids and lipoprotein lipids in type IIa hypercholesterolaemic patients.
Sommariva D; Tirrito M; Bonfiglioli D; Pogliaghi I; Branchi A; Cabrini E
Int J Clin Pharmacol Res; 1986; 6(3):249-53. PubMed ID: 3744628
[TBL] [Abstract][Full Text] [Related]
19. Plasma cholesteryl ester transfer protein is lowered by treatment of hypercholesterolemia with cholestyramine.
Carrilho AJ; Medina WL; Nakandakare ER; Quintão EC
Clin Pharmacol Ther; 1997 Jul; 62(1):82-8. PubMed ID: 9246022
[TBL] [Abstract][Full Text] [Related]
20. Combined drug therapy for familial hypercholesterolemia.
Packard CJ; Stewart JM; Morgan HG; Lorimer AR; Shepherd J
Artery; 1980; 7(4):281-9. PubMed ID: 7213018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]